<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Neuroinflammation is involved in <z:hpo ids='HP_0001297'>stroke</z:hpo> pathophysiology and might be imaged using radioligands targeting the 18 kDa translocator protein (TSPO) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We studied microglial reaction in brain areas remote from the <z:e sem="disease" ids="C1402294" disease_type="Disease or Syndrome" abbrv="">primary lesion</z:e> site in two <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent models</z:e> of focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> (permanent or transient) using [125I]-CLINDE, a promising TSPO single <z:chebi fb="23" ids="30212">photon</z:chebi> emission computed tomography radioligand </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: In a mouse model of permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), ex vivo autoradiographic studies demonstrated, besides in the ischaemic territory, accumulation of [125I]-CLINDE in the ipsilateral thalamus with a binding that progressed up to 3 weeks after MCAO </plain></SENT>
<SENT sid="3" pm="."><plain>[125I]-CLINDE binding markedly decreased in animals pre-injected with either unlabelled CLINDE or PK11195, while no change was observed with <z:chebi fb="0" ids="5103">flumazenil</z:chebi> pre-treatment, demonstrating TSPO specificity </plain></SENT>
<SENT sid="4" pm="."><plain>In rats subjected to transient MCAO, [125I]-CLINDE binding in the ipsilateral thalamus and substantia nigra pars reticulata (SNr) was significantly higher than that in contralateral tissue </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, [125I]-CLINDE binding in the thalamus and SNr was quantitatively correlated to the ischaemic volume assessed by MRI in the cortex and striatum, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Clinical consequences of secondary <z:mp ids='MP_0002229'>neuronal degeneration</z:mp> in <z:hpo ids='HP_0001297'>stroke</z:hpo> might be better treated thanks to the discrimination of neuronal processes using in vivo molecular imaging and potent TSPO radioligands like CLINDE to guide therapeutic interventions </plain></SENT>
</text></document>